statistiche ricercatore

Continente	#
NA - Nord America	1.440
EU - Europa	526
AS - Asia	478
SA - Sud America	70
AF - Africa	17
Continente sconosciuto - Info sul continente non disponibili	1
OC - Oceania	1
Totale	2.533

Nazione	#
US - Stati Uniti d'America	1.421
SG - Singapore	167
IT - Italia	165
GB - Regno Unito	124
CN - Cina	93
VN - Vietnam	64
HK - Hong Kong	61
SE - Svezia	57
BR - Brasile	54
DE - Germania	42
FR - Francia	26
RU - Federazione Russa	26
TR - Turchia	25
FI - Finlandia	21
UA - Ucraina	13
ID - Indonesia	12
IN - India	11
KR - Corea	9
BG - Bulgaria	8
CZ - Repubblica Ceca	8
AR - Argentina	7
CA - Canada	7
BE - Belgio	6
JP - Giappone	6
MX - Messico	6
NL - Olanda	6
IQ - Iraq	5
MY - Malesia	5
ZA - Sudafrica	5
ES - Italia	4
LT - Lituania	4
MA - Marocco	4
PL - Polonia	4
AE - Emirati Arabi Uniti	3
AT - Austria	3
BD - Bangladesh	3
IR - Iran	3
AZ - Azerbaigian	2
BA - Bosnia-Erzegovina	2
CO - Colombia	2
DZ - Algeria	2
IE - Irlanda	2
JM - Giamaica	2
KE - Kenya	2
KG - Kirghizistan	2
PE - Perù	2
SA - Arabia Saudita	2
TN - Tunisia	2
UY - Uruguay	2
AU - Australia	1
BH - Bahrain	1
BZ - Belize	1
CH - Svizzera	1
CL - Cile	1
CR - Costa Rica	1
EC - Ecuador	1
EG - Egitto	1
EU - Europa	1
GD - Grenada	1
JO - Giordania	1
LA - Repubblica Popolare Democratica del Laos	1
NO - Norvegia	1
PA - Panama	1
PH - Filippine	1
PK - Pakistan	1
RS - Serbia	1
SD - Sudan	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
VE - Venezuela	1
Totale	2.533

Nome	#
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes	461
A 5-year clinical follow-up study from the Italian National Registry for FSHD	384
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry	361
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.	312
The Italian FSHD registry: An enhanced data integration and analytics framework for smart health care	284
Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis	266
D4Z4 reduced allele in myopathic subjects with no FSHD phenotype: why inconsistency between molecular and clinical data should prompt us to further investigations.	256
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy	227
Totale	2.551

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	100	0	0	0	0	0	0	0	0	0	44	41	15
2021/2022	236	11	16	46	7	8	10	12	20	28	13	48	17
2022/2023	242	26	30	21	16	39	19	6	23	25	1	19	17
2023/2024	158	2	10	6	14	19	11	11	17	6	11	8	43
2024/2025	381	15	14	3	30	69	57	24	45	47	14	21	42
2025/2026	624	43	18	41	83	132	57	106	21	64	59	0	0
Totale													2.551